戻る
Bone Biologics Corp (BBLG)価格
BBLG 株価推移チャート
BBLG 株価予測
Bone Biologics Corp
$1.78
6.58%
$0.11
終値： Jan 16, 16:00:00 GMT-5
$1.76
-1.12%
$-0.02
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$1.67
始値
$1.68
当日レンジ
$1.67 - $1.88
52週レンジ
$1.3 - $7.74
取引高
142.8K
平均取引高
310.2K
1株当たり利益(TTM)
-7.30
配当利回り
--
時価総額
$3.1M
BBLGとは何ですか？
Bone Biologics Corp. operates as a medical device company. The company is headquartered in Burlington, Massachusetts and currently employs 2 full-time employees. The company went IPO on 2015-11-27. The firm is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.